Current News
Education makes the difference - Gambro launches the online Prismaflex® System Tutorial platform at the 33rd International Symposium on Intensive Care and Emergency Medicine (ISICEM).
News Mar 19, 2013 08:15 GMT
Gambro MARS® receives FDA 510(k) clearance for treatment of Hepatic Encephalopathy
Press Release Jan 24, 2013 16:12 GMTGambro announced today that the U.S. Food and Drug Administration (FDA) has expanded the cleared indications for its Molecular Adsorbent Recirculating System® (MARS) to include the treatment of hepatic encephalopathy (HE) due to a decompensation of a chronic liver disease.
